TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Hims Stock

Hims Stock

forhims.comHealthcareFounded: 2017Funding to Date: $197MM

Hims and hers is a provider of FDA-approved, medical-grade health and wellness products.

Learn more about Hims IPO
Register for Details

For more details on financing and valuation for Hims, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Hims.

Register Today

Team

Management Team

Pat Carroll
Chief Medical Officer
Spencer Lee
Chief Financial Officer
Jack Abraham
Co-Founder & Executive Chairman
Andrew Dudum
Founder & Chief Executive Officer
Joe Spector
Senior Vice President of Partnerships and Operations

Board Members

Thomas Rodgers
Jack Abraham

Other companies like Hims in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Business Insider 08/16/2021
$380 billion juggernaut UnitedHealth is getting into one of the hottest parts of healthcare, and that should be a warning for upstarts like Hims and Ro
UnitedHealth's revamped Optum Store brings new competition to the direct-to-consumer healthcare market.
TechInsider 01/22/2021
The CEO of telemedicine Hims is 'optimistic' about Biden's healthcare plan: 'There's a great sense of relief.'
Hims just went public in a $1.6 billion SPAC deal and the CEO tells Insider he's 'optimistic' about Biden's healthcare plan.
TechInsider 01/21/2021
Hims CEO took a trip to China before COVID hit and still sees Asia as a 'massive market opportunity.'
As the company goes public in a $1.6 billion SPAC deal, the CEO of Hims reveals how he's looking at the Chinese market.

Trending Companies

Frequently Asked Questions